Fig. 1From: Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart reviewFlow Diagram of patient numbers. n (Sample size), UK (United Kingdom), BPA (Bypassing Agents). Total Sample size by prophylactic BPA therapy varies in the results due to missing dataBack to article page